Breast cancer harbouring gene amplification of epidermal growth factor receptor 2 (ERBB2, which encodes HER2) or overexpression of HER2 is categorised as HER2+ breast cancer, which occurs in approximately 15%–20% of all breast cancer cases.1 Here, ERBB2 is linked to breast cancer.